{"created_at":"Fri May 22 22:17:26 +0000 2015","id":601874537391759360,"id_str":"601874537391759360","text":"@JacobPlieth @BrianOverstreet $NVS COSENTYX (secukinumab) label has no mention of any this type of signal: http:\/\/t.co\/0QB2XSzbTr","source":"\u003ca href=\"http:\/\/twitter.com\/#!\/download\/ipad\" rel=\"nofollow\"\u003eTwitter for iPad\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":601871098469347328,"in_reply_to_status_id_str":"601871098469347328","in_reply_to_user_id":873399943,"in_reply_to_user_id_str":"873399943","in_reply_to_screen_name":"JacobPlieth","user":{"id":103011458,"id_str":"103011458","name":"JQ","screen_name":"jq1234t","location":"","url":null,"description":"Biotech Investor","protected":false,"verified":false,"followers_count":1799,"friends_count":130,"listed_count":73,"favourites_count":4311,"statuses_count":4144,"created_at":"Fri Jan 08 15:32:14 +0000 2010","utc_offset":-14400,"time_zone":"Eastern Time (US & Canada)","geo_enabled":false,"lang":"en","contributors_enabled":false,"is_translator":false,"profile_background_color":"C0DEED","profile_background_image_url":"http:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_image_url_https":"https:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_tile":false,"profile_link_color":"0084B4","profile_sidebar_border_color":"C0DEED","profile_sidebar_fill_color":"DDEEF6","profile_text_color":"333333","profile_use_background_image":true,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/1649808935\/IMG_0953_normal.JPG","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/1649808935\/IMG_0953_normal.JPG","profile_banner_url":"https:\/\/pbs.twimg.com\/profile_banners\/103011458\/1355119361","default_profile":true,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweet_count":0,"favorite_count":0,"entities":{"hashtags":[],"trends":[],"urls":[{"url":"http:\/\/t.co\/0QB2XSzbTr","expanded_url":"http:\/\/www.pharma.us.novartis.com\/product\/pi\/pdf\/cosentyx.pdf","display_url":"pharma.us.novartis.com\/product\/pi\/pdf\u2026","indices":[107,129]}],"user_mentions":[{"screen_name":"JacobPlieth","name":"Jacob Plieth","id":873399943,"id_str":"873399943","indices":[0,12]},{"screen_name":"BrianOverstreet","name":"Brian M. Overstreet","id":1103993629,"id_str":"1103993629","indices":[13,29]}],"symbols":[{"text":"NVS","indices":[30,34]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"low","lang":"en","timestamp_ms":"1432333046659"}
{"created_at":"Sat May 23 19:03:24 +0000 2015","id":602188095199535104,"id_str":"602188095199535104","text":"RT @princetongb: $AMGN drops Brodalumab, IL-17 partnership; Solidifying $NVS front runner position 4 their IL-17, secukinumab (Cosentyx) ap\u2026","source":"\u003ca href=\"http:\/\/twitter.com\/download\/android\" rel=\"nofollow\"\u003eTwitter for Android\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":2926129144,"id_str":"2926129144","name":"Bursatil Biotech","screen_name":"Bursatilbiotech","location":"Buenos Aires, Argentina.","url":"http:\/\/puertofinanzas.com\/BursatilBiotech","description":"Estudiante de Econom\u00eda UBA\/ Especialista Sector de Biotecnolog\u00eda cotizando en Nasdaq \/Conduciendo C\u00f3digo Financiero @columnacodigo  Lunes 14hrs x @desdelabolsa","protected":false,"verified":false,"followers_count":239,"friends_count":127,"listed_count":15,"favourites_count":536,"statuses_count":1225,"created_at":"Wed Dec 17 01:03:27 +0000 2014","utc_offset":null,"time_zone":null,"geo_enabled":true,"lang":"es","contributors_enabled":false,"is_translator":false,"profile_background_color":"1A1B1F","profile_background_image_url":"http:\/\/abs.twimg.com\/images\/themes\/theme9\/bg.gif","profile_background_image_url_https":"https:\/\/abs.twimg.com\/images\/themes\/theme9\/bg.gif","profile_background_tile":false,"profile_link_color":"DD2E44","profile_sidebar_border_color":"000000","profile_sidebar_fill_color":"000000","profile_text_color":"000000","profile_use_background_image":true,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/598610389375590400\/FotEHojK_normal.jpg","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/598610389375590400\/FotEHojK_normal.jpg","profile_banner_url":"https:\/\/pbs.twimg.com\/profile_banners\/2926129144\/1425314172","default_profile":false,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweeted_status":{"created_at":"Sat May 23 16:02:14 +0000 2015","id":602142502418714624,"id_str":"602142502418714624","text":"$AMGN drops Brodalumab, IL-17 partnership; Solidifying $NVS front runner position 4 their IL-17, secukinumab (Cosentyx) approved in January.","source":"\u003ca href=\"https:\/\/about.twitter.com\/products\/tweetdeck\" rel=\"nofollow\"\u003eTweetDeck\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":597480797,"id_str":"597480797","name":"Beck","screen_name":"princetongb","location":"Princeton, NJ","url":null,"description":null,"protected":false,"verified":false,"followers_count":402,"friends_count":195,"listed_count":19,"favourites_count":1245,"statuses_count":2216,"created_at":"Sat Jun 02 15:02:39 +0000 2012","utc_offset":-10800,"time_zone":"Atlantic Time (Canada)","geo_enabled":false,"lang":"en","contributors_enabled":false,"is_translator":false,"profile_background_color":"C0DEED","profile_background_image_url":"http:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_image_url_https":"https:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_tile":false,"profile_link_color":"0084B4","profile_sidebar_border_color":"C0DEED","profile_sidebar_fill_color":"DDEEF6","profile_text_color":"333333","profile_use_background_image":true,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/493408502178512897\/iJH7hwJp_normal.jpeg","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/493408502178512897\/iJH7hwJp_normal.jpeg","default_profile":true,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweet_count":1,"favorite_count":0,"entities":{"hashtags":[],"trends":[],"urls":[],"user_mentions":[],"symbols":[{"text":"AMGN","indices":[0,5]},{"text":"NVS","indices":[55,59]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"low","lang":"en"},"retweet_count":0,"favorite_count":0,"entities":{"hashtags":[],"trends":[],"urls":[],"user_mentions":[{"screen_name":"princetongb","name":"Beck","id":597480797,"id_str":"597480797","indices":[3,15]}],"symbols":[{"text":"AMGN","indices":[17,22]},{"text":"NVS","indices":[72,76]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"low","lang":"en","timestamp_ms":"1432407804666"}
